Evidence map›Paper›PMID 28803712›Full record

ArticleVaccine2017

Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016.

Delphine Sauvageot, Christel Saussier, Abebe Gobeze, Sikhona Chipeta, Innocent Mhango, Gift Kawalazira, Martin A Mengel, Dominique Legros, Philippe Cavailler, Maurice M'bang'ombe

Open access · hybridAbstract read
In one paragraph

Article in Vaccine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Delphine SauvageotAgence de Médecine Préventive, Paris, France. Electronic address: dsauvageot@aamp.org.
Christel SaussierAgence de Médecine Préventive, Paris, France. Electronic address: csaussier@aamp.org.
Abebe GobezeUNICEF, Malawi Country Office, Lilongwe, Malawi. Electronic address: agobeze@gmail.com.
Sikhona ChipetaMinistry of Health, Community Health Sciences Unit, Lilongwe, Malawi. Electronic address: smchipeta@gmail.com.
Innocent MhangoMinistry of Health, District Health Office, Machinga, Malawi. Electronic address: innocentmhango@gmail.com.
Gift KawalaziraMinistry of Health, District Health Office, Zomba, Malawi. Electronic address: gkawalazira@yahoo.co.uk.
Martin A MengelAgence de Médecine Préventive, Paris, France. Electronic address: mmengel@aamp.org.
Dominique LegrosWorld Health Organization, Geneva, Switzerland. Electronic address: legrosd@who.int.
Philippe CavaillerAgence de Médecine Préventive, Paris, France. Electronic address: pcavailler@aamp.org.
Maurice M'bang'ombeMinistry of Health, Community Health Sciences Unit, Lilongwe, Malawi. Electronic address: mbangombe@yahoo.com.
Agence de Médecine Préventive · FRMinistry of Health · MWWorld Health Organization · CHWorld Health Organization - Malawi · MW

Funding

World Health Organization 001
6 · The paper itself

Abstract

contextFrom December 2015 to August 2016, a large epidemic of cholera affected the fishermen of Lake Chilwa in Malawi. A first reactive Oral Cholera Vaccines (OCV) campaign was organized, in February, in a 2km radius of the lake followed by a preemptive one, conducted in November, in a 25km radius. We present the vaccine coverage reached in hard-to-reach population using simplified delivery strategies.

methodWe conducted two-stage random-sampling cross-sectional surveys among individuals living in a 2km and 25km radius of Lake Chilwa (islands and floating homes included). Individuals aged 12months and older from Machinga and Zomba districts were sampled: 43 clusters of 14 households were surveyed. Simplified strategies were used for those living in islands and floating homes: self- delivery and community-supervised delivery of the second dose. Vaccine coverage (VC) for at-least-two-doses was estimated taking into account sampling weights and design effects.

resultsA total of 1176 households were surveyed (2.7% of non-response). Among the 2833 individuals living in the 2km radius of Lake and the 2915 in the 25km radius: 457 (16.1%) and 239 (8.2%) lived in floating homes or on islands at some point in the year, respectively. For the overall population, VC was 75.6% and 54.2%, respectively. In the 2km radius, VC was 92.2% for those living on the lake at some point of the year: 271 (64.8%) used the simplified strategies. The main reasons for non-vaccination were absence during the campaign and vaccine shortage. Few adverse events occurring in the 24h following vaccination was reported.

conclusionsWe reached a high two-dose coverage of the most at-risk population using simplified delivery strategies. Because of the high fishermen mobility, regular catch-up campaigns or another strategy specifically targeting fishermen need to be assessed for more efficient vaccines use.

Indexed as

Administration, OralAdolescentChildChild, PreschoolCholeraCholera VaccinesCross-Sectional StudiesDisease OutbreaksHumansInfantMalawiMass VaccinationVaccinationCholera VaccinesAEFICholeraFishermenMalawiOral cholera vaccineVaccine coverage

Identifiers

PMID28803712
PMCPMC5594244
OpenAlexW2742625593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.